Prediction of gross post-transplant outcomes based on the intra-operative decline in C-reactive protein in living donor liver transplantation

Transplant Proc. 2015 Mar;47(2):431-7. doi: 10.1016/j.transproceed.2015.01.005.

Abstract

Background: C-reactive protein (CRP), a marker of infection and inflammation, is produced mainly in the liver. Its slow onset and various influencing factors have limited studies on the intra-operative changes in CRP in living donor liver transplantation (LDLT). In this study, we asked whether the intra-operative changes in CRP predicts post-transplant outcome.

Methods: The peri-transplant data of 263 LDLT patients were reviewed. "Intra-operative CRP decline" was calculated by subtracting the pretransplant CRP from the 1-day post-transplant CRP. A negative value defined an intra-operative decline. Peri-transplant variables were compared between patients with and without gross post-transplant outcomes (GPOs), including death, allograft dysfunction, infection, and kidney injury. Multivariate logistic regression was used to develop a model to predict GPO, and area receiver operating characteristic curve (AUC) analysis was used to evaluate the prognostic accuracies for GPO.

Results: GPOs were determined in 95 LDLT patients (36.1%). GPO-positive patients had a lesser change in CRP levels (0.51 versus 1.16 mg/dL) and a higher incidence of a decline in CRP (34.7% versus 13.7%) during LDLT (P < .05) than did GPO-negative patients. The AUC of the intra-operative CRP change (0.585; P = .018) did not significantly differ from that of the pretransplant CRP. After multivariate adjustment, a patient with an intra-operative decline in CRP had a 3.21-fold higher risk for GPO occurrence (P = .001).

Conclusions: GPO occurrence was related to the intra-operative decline of CRP in LDLT patients. However, multivariate compensation might be required for the clinical utilization of intra-operative decline in CRP as a prognostic indicator.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • C-Reactive Protein / metabolism*
  • Decision Support Techniques*
  • End Stage Liver Disease / blood
  • End Stage Liver Disease / surgery*
  • Female
  • Humans
  • Intraoperative Period
  • Liver Transplantation / methods
  • Liver Transplantation / mortality*
  • Living Donors*
  • Logistic Models
  • Male
  • Middle Aged
  • Postoperative Complications / diagnosis*
  • Preoperative Period
  • Primary Graft Dysfunction / diagnosis*
  • Prognosis
  • ROC Curve
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Biomarkers
  • C-Reactive Protein